Cargando…
Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma
Current prenatal diagnosis for fetal aneuploidies (including trisomy 21 [T21]) generally relies on an initial biochemical serum-based noninvasive prenatal testing (NIPT) after which women who are deemed to be at high risk are offered an invasive confirmatory test (amniocentesis or chorionic villi sa...
Autores principales: | Gekas, Jean, Langlois, Sylvie, Ravitsky, Vardit, Audibert, François, van den Berg, David-Gradus, Haidar, Hazar, Rousseau, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104725/ https://www.ncbi.nlm.nih.gov/pubmed/25053891 http://dx.doi.org/10.2147/TACG.S35602 |
Ejemplares similares
-
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues
por: Gekas, Jean, et al.
Publicado: (2016) -
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well
as Down syndrome: an international collaborative study
por: Palomaki, Glenn E., et al.
Publicado: (2012) -
Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011) -
An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019) -
Misdiagnosis of trisomy 13 and trisomy 18 is more common than anticipated
por: Geddes, Gabrielle C., et al.
Publicado: (2022)